BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 32319585)

  • 1. PHLPP2 is a novel biomarker and epigenetic target for the treatment of vitamin C in pancreatic cancer.
    Chen L; Song H; Luo Z; Cui H; Zheng W; Liu Y; Li W; Luo F; Liu J
    Int J Oncol; 2020 May; 56(5):1294-1303. PubMed ID: 32319585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes.
    Eyres M; Lanfredini S; Xu H; Burns A; Blake A; Willenbrock F; Goldin R; Hughes D; Hughes S; Thapa A; Vavoulis D; Hubert A; D'Costa Z; Sabbagh A; Abraham AG; Blancher C; Jones S; Verrill C; Silva M; Soonawalla Z; Maughan T; Schuh A; Mukherjee S; O'Neill E
    Gastroenterology; 2021 Aug; 161(2):653-668.e16. PubMed ID: 33915173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic priming targets tumor heterogeneity to shift transcriptomic phenotype of pancreatic ductal adenocarcinoma towards a Vitamin D susceptible state.
    He B; Stoffel L; He CJ; Cho K; Li AM; Jiang H; Flowers BM; Nguyen KT; Wang KW; Zhao AY; Zhou MN; Ferreira S; Attardi LD; Ye J
    Cell Death Dis; 2024 Jan; 15(1):89. PubMed ID: 38272889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAP1L5 facilitates pancreatic ductal adenocarcinoma progression via TRIM29-mediated ubiquitination of PHLPP1.
    Xiao B; Ge Y; Zhao R; Zhang Y; Guo Y; Zhang S; Li B; Qiu P; Chao Z; Zuo S
    Biochem Pharmacol; 2023 Nov; 217():115811. PubMed ID: 37717692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors.
    Mazarico JM; Sánchez-Arévalo Lobo VJ; Favicchio R; Greenhalf W; Costello E; Carrillo-de Santa Pau E; Marqués M; Lacal JC; Aboagye E; Real FX
    Mol Cancer Ther; 2016 Feb; 15(2):323-33. PubMed ID: 26769123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic therapeutic strategies in pancreatic cancer.
    Orlacchio A; Muzyka S; Gonda TA
    Int Rev Cell Mol Biol; 2024; 383():1-40. PubMed ID: 38359967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PHLPP2: A Prognostic Biomarker in Adenocarcinoma of the Rectum.
    Xie K
    Turk J Gastroenterol; 2023 Oct; 34(10):1099-1106. PubMed ID: 37737218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Src is a target molecule of mannose against pancreatic cancer cells growth in vitro & in vivo.
    Xie J; Wu S; Liao W; Ning J; Ding K
    Glycobiology; 2023 Oct; 33(10):766-783. PubMed ID: 37658770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated epigenetic biomarkers in circulating cell-free DNA as a robust classifier for pancreatic cancer.
    Cao F; Wei A; Hu X; He Y; Zhang J; Xia L; Tu K; Yuan J; Guo Z; Liu H; Xie D; Li A
    Clin Epigenetics; 2020 Jul; 12(1):112. PubMed ID: 32703318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts.
    Bhagat TD; Von Ahrens D; Dawlaty M; Zou Y; Baddour J; Achreja A; Zhao H; Yang L; Patel B; Kwak C; Choudhary GS; Gordon-Mitchell S; Aluri S; Bhattacharyya S; Sahu S; Bhagat P; Yu Y; Bartenstein M; Giricz O; Suzuki M; Sohal D; Gupta S; Guerrero PA; Batra S; Goggins M; Steidl U; Greally J; Agarwal B; Pradhan K; Banerjee D; Nagrath D; Maitra A; Verma A
    Elife; 2019 Nov; 8():. PubMed ID: 31663852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drivers of Gene Expression Dysregulation in Pancreatic Cancer.
    Venkat S; Alahmari AA; Feigin ME
    Trends Cancer; 2021 Jul; 7(7):594-605. PubMed ID: 33618999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual Oxidase-Induced Sustained Generation of Hydrogen Peroxide Contributes to Pharmacologic Ascorbate-Induced Cytotoxicity.
    Gibson AR; O'Leary BR; Du J; Sarsour EH; Kalen AL; Wagner BA; Stolwijk JM; Falls-Hubert KC; Alexander MS; Carroll RS; Spitz DR; Buettner GR; Goswami PC; Cullen JJ
    Cancer Res; 2020 Apr; 80(7):1401-1413. PubMed ID: 32041838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma.
    Ferguson LP; Gatchalian J; McDermott ML; Nakamura M; Chambers K; Rajbhandari N; Lytle NK; Rosenthal SB; Hamilton M; Albini S; Wartenberg M; Zlobec I; Galván JA; Karamitopoulou E; Vavinskaya V; Wascher A; Lowy AM; Schürch CM; Puri PL; Bruneau BG; Hargreaves DC; Reya T
    Nat Commun; 2023 Jan; 14(1):292. PubMed ID: 36653361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of PPPCs family reveals the clinical significance of PPP1CA and PPP4C in breast cancer.
    Xie W; Sun Y; Zeng Y; Hu L; Zhi J; Ling H; Zheng X; Ruan X; Gao M
    Bioengineered; 2022 Jan; 13(1):190-205. PubMed ID: 34964699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic control of pancreatic cancer metastasis.
    Krauß L; Schneider C; Hessmann E; Saur D; Schneider G
    Cancer Metastasis Rev; 2023 Dec; 42(4):1113-1131. PubMed ID: 37659057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blue light promotes vitamin C-mediated ferroptosis of melanoma through specifically upregulating transporter SVCT2 and generating Fe
    Yang R; Deng F; Yang Y; Tian Q; Huangfu S; Yang L; Hou J; Yang G; Pang W; Lu J; Liu H; Chen Y; Gao J; Zhang L
    Biomaterials; 2023 Aug; 299():122186. PubMed ID: 37276798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic plasticity in PDAC.
    Kelsey R
    Nat Cancer; 2023 Dec; 4(12):1646. PubMed ID: 38102359
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacologic Ascorbate and DNMT Inhibitors Increase DUOX Expression and Peroxide-Mediated Toxicity in Pancreatic Cancer.
    Steers GJ; O'Leary BR; Du J; Wagner BA; Carroll RS; Domann FE; Goswami PC; Buettner GR; Cullen JJ
    Antioxidants (Basel); 2023 Aug; 12(9):. PubMed ID: 37759986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Roles for Vitamin D Superagonists: From COVID to Cancer.
    Easty DJ; Farr CJ; Hennessy BT
    Front Endocrinol (Lausanne); 2021; 12():644298. PubMed ID: 33868174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk between metabolic remodeling and epigenetic reprogramming: A new perspective on pancreatic cancer.
    Ren J; Ren B; Liu X; Cui M; Fang Y; Wang X; Zhou F; Gu M; Xiao R; Bai J; You L; Zhao Y
    Cancer Lett; 2024 Apr; 587():216649. PubMed ID: 38311052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.